DEADLINE APPROACHING: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025

Key Takeaways:

• A securities class action lawsuit has been filed against Elevance Health, Inc.
• Berger Montague PC advises affected investors to act by July 11, 2025.
• The lawsuit concerns purchasers of Elevance securities between April 18 and an unspecified date.
• Elevance Health is listed on the NYSE under the ticker symbol ELV.
• The announcement was made on June 25, 2025, in Philadelphia.

Investors Urged to Act as Deadline Nears

Investors who have purchased shares of Elevance Health, Inc. are being notified of an important deadline concerning a securities class action lawsuit filed against the company. Berger Montague PC, a law firm specializing in complex litigation, has advised that affected shareholders must inquire about the class action by July 11, 2025.

About Elevance Health, Inc.

Elevance Health, Inc., traded on the New York Stock Exchange under the ticker symbol ELV, is a significant player in the healthcare industry. The company has attracted numerous investors over the years due to its market presence.

Details of the Lawsuit

The securities class action lawsuit has been filed on behalf of investors who purchased Elevance securities between April 18 and an unspecified date. While specific allegations have not been detailed, such lawsuits typically address concerns over possible securities fraud or misrepresentation that may have affected the value of the company’s shares.

Advisory from Berger Montague PC

Berger Montague PC announced on June 25, 2025, in Philadelphia that they are representing investors in this class action. The firm is known for its expertise in securities litigation and is encouraging all affected investors to reach out and inquire about their rights.

Importance of the July 11 Deadline

The firm highlights the critical nature of the upcoming July 11, 2025 deadline. Investors who fail to act before this date may lose the opportunity to participate in any potential recovery or settlement resulting from the lawsuit.

Implications for Investors

This legal action may have significant implications for shareholders of Elevance Health, Inc. Investors are urged to consider their options and the potential impact on their investments. Prompt action is recommended to ensure that their rights are protected.

Conclusion

As the deadline approaches, it is imperative for affected Elevance Health investors to be proactive. Those who purchased securities within the specified timeframe should contact Berger Montague PC to understand their rights and the steps they need to take before July 11, 2025.